No Data
No Data
BioCryst Pharmaceuticals Insiders Added US$1.05m Of Stock To Their Holdings
BioCryst Pharmaceuticals(BCRX.US) Director Sells US$54,352 in Common Stock
$BioCryst Pharmaceuticals(BCRX.US)$ Director McKee Amy E sold 8,600 shares of common stock on Jun 24, 2024 at an average price of $6.32 for a total value of $54,352.Source: Announcement What is statem
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
Shareholders Have Faith in Loss-making BioCryst Pharmaceuticals (NASDAQ:BCRX) as Stock Climbs 4.1% in Past Week, Taking Five-year Gain to 69%
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore, you'd generally like to see the share price rise faster than the market. But BioCry
TD Cowen Maintains BioCryst Pharmaceuticals(BCRX.US) With Buy Rating, Maintains Target Price $20
TD Cowen analyst Stacy Ku maintains $BioCryst Pharmaceuticals(BCRX.US)$ with a buy rating, and maintains the target price at $20.According to TipRanks data, the analyst has a success rate of 22.7% and
BioCryst Pharmaceuticals(BCRX.US) Director Sells US$28,134 in Common Stock
$BioCryst Pharmaceuticals(BCRX.US)$ Director SANDERS MACHELLE sold 4,689 shares of common stock on Jun 17, 2024 at an average price of $6 for a total value of $28,134.Source: Announcement What is stat